Psychological Characteristics of Patients with Metabolic Syndrome

Relevance. Metabolic syndrome (MS), which encompasses a combination of non-insulindependent diabetes mellitus, hypertension, hypercholesterolemia and hyperlipidemia, causes patients to experience, among other things, psychoemotional stress due to the presence of vital fears and changes in the quality of life. Patients with metabolic syndrome complain not only of a somatic nature (shortness of breath, headaches, decreased exercise tolerance, unstable blood pressure, etc.) but also of a psychological profile, most of them are in a state of chronic stress, which generates emotional–affective and psychovegetative disorders.
Intention. To identify the psychological characteristics of patients with metabolic syndrome in order to improve the effectiveness of the developed programs in the process of treatment of methods of psychological correction and physical therapy.
Materials and methods. The study conducted on the basis of the private multidisciplinary clinic “SANAVITA Medical Center” involved 32 people, 8 men and 24 women aged 40 to 60 years with a confirmed diagnosis of metabolic syndrome. The psychological state of people with this diagnosis was assessed to determine the expediency of additional use of psychological correction methods in the course of therapy and rehabilitation. The study sample was divided into 2 groups. With participants in the group 1 including 16 people in addition to the therapeutic effects performed on the participants in the group 2 (16 people), psychotherapeutic effects were performed using the method of Cognitive behavioral psychotherapy.
Results. The average profile of the components of the response to the disease of the study participants demonstrates the predominance among respondents of denial of the disease, “withdrawal” to work, as well as a harmonious attitude to the disease, readiness for treatment. There is a predominance of the “adaptive” disease response unit in the sample (50 % of the study sample). At the same time, 21.88 % of respondents belong to diffuse type 2, which includes apathy, anxiety, melancholia, hypochondria, sensitivity, egocentrism, paranoia and dysphoria. 9.38 % of the sample have diffuse type 1 and interpsychic types of response to the disease, including anxious, hypochondriac, neurasthenic, melancholic and apathetic response components. High scores on the scales of anxiety and depression were determined in patients before psychological correction in both groups. After conducting a group short-term psychocorrection program, it was found that among the patients of the group undergoing the psychocorrection program, after its completion, the level of depression and anxiety significantly decreased. In the group 2, changes in the values of the studied indicators were less pronounced.
Conclusion. The additional implementation of a short-term psychocorrective program using the method of Cognitive behavioral psychotherapy helps to optimize treatment and rehabilitation measures for patients, and the tactics of introducing this program into the rehabilitation process should be considered justified.

1. Bespalova I.D. Vospalitel’nyi protsess v patogeneze metabolicheskogo sindroma [Inflammatory process in the pathogenesis of metabolic syndrome] : Dissertation Dr. Med. Sci. Tomsk, 2016. 333 p. (In Russ.)

2. Voznesenskaya T.G. Rasstroistva pishchevogo povedeniya pri ozhirenii i ikh korrektsiya [Eating disorders in obesity and their correction]. Ozhirenie i metabolizm [Obesity and metabolism]. 2004; (2): 2–6. (In Russ.)

3. Garganeeva N.P., Belokrylova M.F., Tyukalova L.I., Lebedeva V.F. Vliyanie nevroticheskikh i affektivnykh rasstroistv na formirovanie prediktorov ishemicheskoi bolezni serdtsa i narushenii uglevodnogo i zhirovogo obmenov [The influence of neurotic and affective disorders on the formation of predictors of coronary heart disease and disorders of carbohydrate and fat metabolism]. Byulleten’ sibirskoi meditsiny [Bulletin of Siberian Medicine]. 2015; 14(5): 22–28. (In Russ.)

4. Garganeeva N.P., Tyukalova L.I., Belokrylova M.F., [et al.]. Vtorichnaya profilaktika serdechnososudistykh zabolevanii, assotsiirovannykh s trevozhnymi i depressivnymi rasstroistvami: puti optimizatsii [Secondary prevention of cardiovascular diseases associated with anxiety and depressive disorders: optimization paths]. Uchenye zapiski Sankt-Peterburgskogo gosudarstvennogo meditsinskogo universiteta imeni akad. I.P. Pavlova [Scientific Notes of St. Petersburg State Medical University]. 2013; 20(3): 26–28. (In Russ.)

5. Dzherieva I.S., Volkova N.I., Rapoport S.I. Assotsiatsiya mezhdu depressiei i metabolicheskim sindromom [Association between depression and metabolic syndrome]. Klinicheskaya meditsina [Clinical medicine]. 2015; (1): 62–65. (In Russ.)

6. Drapkina O.M., Kupreishvili L.V., Fomin V.V. Kompozitsionnyi sostav tela i ego rol’ v razvitii metabolicheskikh narushenii i serdechno-sosudistykh zabolevanii [Body composition and its role in the development of metabolic disorders and cardiovascular diseases]. Kardiovaskulyarnaya terapiya i profilaktika [Cardiovascular therapy and prevention]. 2017; 16(5): 81–88. (In Russ.)

7. Drapkina O.M., Shepel R.N., Kaburova A.N. Otsenka sub”ektivnoi situatsionnoi i lichnostnoi trevozhnosti u lits s izbytochnoi massoi tela [Assessment of subjective situational and personal anxiety in individuals with excess body weight]. Neotlozhnaya kardiologiya i kardiovaskulyarnye riski. [Emergency cardiology and cardiovascular risks]. 2017; 1(1): 83–88. (In Russ.)

8. Zhuravlev Yu.I., Tkhorikova V.N. Evolyutsiya predstavlenii o kriteriyakh diagnostiki i epidemiologii metabolicheskogo sindroma (obzor literatury) [Evolution of ideas about the criteria for diagnosis and epidemiology of metabolic syndrome (literature review)]. Profilakticheskaya meditsina [Preventive medicine]. 2014; (4): 52–56. (In Russ.)

9. Kalashnikova M.F. Metabolicheskii sindrom: sovremennyi vzglyad na kontseptsiyu, metody profilaktiki i lecheniya [Metabolic syndrome: a modern look at the concept, methods of prevention and treatment]. Effektivnaya farmakoterapiya [Effective pharmacotherapy]. 2013; (55): 52–63. (In Russ.)

10. Makolkin V.I. Metabolicheskii sindrom [Metabolic syndrome]. Moscow, 2010. 144 p. (In Russ.)

11. Mamedov M.N. Metabolicheskii sindrom v Rossii: rasprostranennost’, klinicheskie osobennosti i lechenie [Metabolic syndrome in Russia: prevalence, clinical features and treatment]. Moscow, 2011.160 p. (In Russ.)

12. Melnik O.S. Spetsifika individual’nogo reagirovaniya patsienta na bolezn’: vvedenie v problemu [Specificity of the patient’s individual response to the disease: an introduction to the problem]. Molodezhnyi sbornik nauchnykh statei «Nauchnye stremleniya» [Youth collection of scientific articles “Scientific Aspirations”]. 2016; (20): 143–144. (In Russ.)

13. Misnikova I.V., Kovaleva Yu.A. Vliyanie fizicheskoi nagruzki na obmennye protsessy u patsientov s metabolicheskim sindromom [The influence of physical activity on metabolic processes in patients with metabolic syndrome]. Russkii meditsinskii zhurnal [Russian Medical Journal]. 2018; 26(1): 8–11. (In Russ.)

14. Pinkhasov B.B., Selyatitskaya V.G., Lutov Yu.V., Deev D.A. Metabolicheskii sindrom i ego komponenty kak kriterii otsenki effektivnosti lecheniya gipertonicheskoi bolezni [Metabolic syndrome and its components as criteria for assessing the effectiveness of hypertension treatment]. Byulleten’ sibirskoi meditsiny [Bulletin of Siberian Medicine]. 2018; 17(4): 122–130. (In Russ.)

15. Roitberg G.I., Dorosh Zh.V., Sharkhun O.O. Vliyanie insulinorezistentnosti na formirovanie i progressirovanie komponentov metabolicheskogo sindroma (itogi pyatiletnego issledovaniya) [The influence of insulin resistance on the formation and progression of metabolic syndrome components (results of a five-year study)]. Ratsional’naya farmakoterapiya v kardiologiiа [Rational pharmacotherapy in cardiology]. 2015; 11(2): 132–138. (In Russ.)

16. Roitberg G.E., Slastnikova I.D., Dorosh Zh.V., Dmitrieva O.Yu. Vliyanie fizicheskoi nagruzki na osnovnye komponenty metabolicheskogo sindroma [The influence of physical activity on the main components of metabolic syndrome]. Profilakticheskaya meditsina [Preventive Medicine]. 2016; 19(3): 28–33. (In Russ.)

17. Salmina-Khvostova O.I. Rasstroistva pishchevogo povedeniya pri ozhirenii (epidemiologicheskii, klinikodinamicheskii, preventivnyi, reabilitatsionnyi aspekty): [Eating disorders in obesity (epidemiological, clinicaldynamic, preventive, rehabilitation aspects)] : Dissertation Dr. Med. Sci. Tomsk, 2008. 304 p. (In Russ.)

18. Uspenskii Yu.P., Petrenko Yu.V., Gulunov Z.Kh. [et al.]. Metabolicheskii sindrom [Metabolic syndrome]. St. Petersburg, 2017. 60 p. (In Russ.)

19. Uchamprina V.A., Romantsova T.I., Kalashnikova M.F. Kompleksnyi podkhod v lechenii metabolicheskogo sindroma [An integrated approach to the treatment of metabolic syndrome]. Ozhirenie i metabolizm [Obesity and metabolism]. 2014; 11(1): 32–37. (In Russ.)

20. Chumakova G.A., Veselovskaya N.G., Gritsenko O.V., Ott A.V. Metabolicheskii sindrom: slozhnye i nereshennye problemy [Metabolic syndrome: complex and unresolved problems]. Rossiiskii kardiologicheskii zhurnal [Russian Journal of Cardiology]. 2014; (3(107)): 63–71. (In Russ.)

21. Shavlovskaya O.A., Kuznetsov S.L. Korrektsiya trevozhnykh narushenii: fokus na komorbidnogo patsienta [Correction of anxiety disorders: focus on the comorbid patient]. Terapevticheskii arkhiv. [Therapeutic archive]. 2018; 90(1): 67–71. (In Russ.)

22. Kaplan J., Katon W.J. Epidemiology and treatment of depression in patients with chronic medical illness. Dialogues Clin Neurosci. 2015; 13(1): 7–23.

23. Lipsy R.J. The national cholesterol education program adult treatment panel III guidelines. J Manag Care Pharm. 2003; 9 (1 Suppl): 2–5.

24. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988; 37(12): 1595–1607.